IMMUTEP Ltd Files Form 6-K
Ticker: PRRUF · Form: 6-K · Filed: Jul 17, 2024 · CIK: 1506184
| Field | Detail |
|---|---|
| Company | Immutep Ltd (PRRUF) |
| Form Type | 6-K |
| Filed Date | Jul 17, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 6-K, company-update
TL;DR
IMMUTEP Ltd (formerly Prima BioMed) filed a 6-K on July 17, 2024, updating its SEC information.
AI Summary
On July 17, 2024, IMMUTEP Ltd filed a Form 6-K. The company, previously known as Prima BioMed Ltd, is incorporated in Australia and operates in the Pharmaceutical Preparations sector. Its principal executive offices are located in Sydney, NSW.
Why It Matters
This filing provides routine updates to the SEC, indicating ongoing compliance and operational status for IMMUTEP Ltd, a publicly traded company.
Risk Assessment
Risk Level: low — This filing is a routine administrative update and does not contain new material financial or operational information that would typically increase risk.
Key Players & Entities
- IMMUTEP Ltd (company) — Registrant
- Prima BioMed Ltd (company) — Former company name
- July 17, 2024 (date) — Filing date
- 20240717 (date) — Filing date
- 001-35428 (other) — SEC file number
- Level 32, Australia Square 264 George Street, Sydney NSW 2000, Australia (address) — Principal executive office address
FAQ
What is the primary purpose of this Form 6-K filing?
The Form 6-K is a report of a foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used to provide routine updates to the SEC.
When was this Form 6-K filed?
The filing was made on July 17, 2024.
What was IMMUTEP Ltd's former name?
IMMUTEP Ltd was formerly known as Prima BioMed Ltd.
Where are IMMUTEP Ltd's principal executive offices located?
The principal executive offices are located at Level 32, Australia Square 264 George Street, Sydney NSW 2000, Australia.
Under which SEC Act is this form filed?
This form is filed under the Securities Exchange Act of 1934.
Filing Stats: 264 words · 1 min read · ~1 pages · Grade level 17.5 · Accepted 2024-07-17 07:47:27
Filing Documents
- d779880d6k.htm (6-K) — 10KB
- d779880dex991.htm (EX-99.1) — 12KB
- g779880page5.jpg (GRAPHIC) — 8KB
- 0001193125-24-180005.txt ( ) — 34KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Dated: July 17, 2024 IMMUTEP LIMITED By: /s/ Marc Voigt Name: Marc Voigt Title: Chief Executive Officer